M&A analysis: signs of life emerge
Some big deals in the second quarter have raised hopes that takeouts are back.
Some big deals in the second quarter have raised hopes that takeouts are back.
Adcetris bags its eighth approval, while SpringWorks and Ono also feature.
The deal isn’t done, but would be Merck’s biggest oncology buy.